Formulation and use of a fusion protein
OwnerDaocheng ZHUinventor
Life of this patent
Estimating the term…
Abstract
The present invention pertains to the biomedical field, and particularly relates to a solid formulation of a fusion protein, said solid formulation consists of particulates comprising a fusion protein and at least one carrier, and a method of preparing the solid formulation. The present invention further pertains to a method of treating allergic rhinitis in an individual, the method comprises administering to the individual a therapeutically effective amount of the solid formulation of the fusion protein.
Claims14
A solid formulation of a fusion protein, wherein said solid formulation consists of particulates comprising a fusion protein and at least one carrier, and the fusion protein is a protein comprising the amino acid sequence of SEQ ID No. 2 or is at least 60%, 70%, 80%, 90%, 95%, 96%, 97%, 98%, or 99% identical to SEQ ID No. 2.
Dependencies are inferred from the claim text.